PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26551344-7	2016	The systemic administration of PEG-PLGA or PEG-PLGA/PLGA NPs containing sorafenib twice per week for a period of 4 weeks efficiently ameliorated liver fibrosis, as indicated by decreased alpha-smooth muscle actin (alpha-SMA) content and collagen production in the livers of CCl4-treated mice.	Sorafenib	72-81	actin alpha 2, smooth muscle, aorta	Mus musculus	187-212	
26551344-7	2016	The systemic administration of PEG-PLGA or PEG-PLGA/PLGA NPs containing sorafenib twice per week for a period of 4 weeks efficiently ameliorated liver fibrosis, as indicated by decreased alpha-smooth muscle actin (alpha-SMA) content and collagen production in the livers of CCl4-treated mice.	Sorafenib	72-81	actin alpha 2, smooth muscle, aorta	Mus musculus	214-223